why choose us

First received: December 14, 2022

Clinical Trial: An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Migraine

Study Type: OBSERVATIONAL


Official Title: A Prospective, Observational Diary Study to Evaluate the Real-World Effectiveness of the Acute Treatment of Migraine With Ubrogepant, When Used in Combination With Atogepant for Prevention

Brief Summary: Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound.This study will how effective the combination use of ubrogepant and atogepant is in treating adult participants with migraine.Change in migraine activity will be assessed.Urogepant (Ubrelvy) and Atogepant (Qulipta) are approved drugs for treatment of migraine in adults in the US.Approximately 432 adult participants who are prescribed Ubrogepant and atogepant…

Read more